Weekly update summarises available data on COVID-19 vaccines

Produced on behalf of the Melbourne Children’s Campus in affiliation with WHO, the update reports on vaccine efficacity and effectiveness, the pipeline for vaccine development and the WHO SAGE timeline for vaccine authorisation.

Since the emergence of SARS-CoV-2 in late 2019, COVID-19 has taken a huge toll globally with over 100 million cases and 2.5 million deaths, as well as long term health impacts and the wide-ranging consequences of lockdowns. The rapid development of multiple vaccines globally has been a tremendous success story for public health. However, it can prove challenging to stay up to date with the increasing literature on various aspects of these vaccines.

The COVID-19 weekly vaccine update summarises the data available on COVID-19 vaccines. It includes the specifications of COVID-19 vaccines; vaccine efficacy and effectiveness, including against variants of concern, comorbidities and the elderly; vaccine safety; the pipeline for vaccine development; and the WHO SAGE timeline for vaccine authorisation. Each week, the document is updated weekly with any newly released information on the vaccines.

The document was compiled in collaboration with the WHO South Pacific Division of Pacific Technical Support (DPS). The main target audience is governments of Pacific Islands Countries, WHO country offices, UNICEF and development partners. The distribution list includes many individuals working in public health, public health associations and media organisations.

To subscribe, email kase.anderson@unimelb.edu.au

Alternatively you can access the update (as well as the historical versions) via COVID-19 weekly vaccine update.

The document is compiled by Dr John Hart, a research clinician at MCRI. Expert oversight is provided by Professor Fiona Russell and Professor Kim Mulholland. Quality checks are conducted by Professor Julie Bines, Associate Professor Nigel Crawford and Associate Professor Margie Danchin.